Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Endocrinology

  • News

    Machine learning–derived risk score predicts heart failure risk in diabetes patients

    September 22, 2019

    Highest WATCH-DM scores linked to 5-year heart failure risk approaching 20%.

  • News

    Dapagliflozin meets primary endpoint in the DAPA-HF trial

    August 21, 2019

    AstraZeneca announces preliminary results in first heart failure trial in an SGLT2 inhibitor.

  • News

    New biomarker model outmatches conventional risk factors for predicting mortality

    August 20, 2019

    Although the majority of these biomarkers have been associated with mortality before, this is the first study that shows their independent effect when combined into one model.

  • 1
    News

    FDA approves Baqsimi nasal powder for emergency hypoglycemia treatment

    July 25, 2019

    It is the first glucagon therapy approved for this indication that is administrable without an injection.

  • 1
    News

    FDA issues warning on insulin pump cybersecurity weakness

    June 28, 2019

    The MiniMed 508 and MiniMed Paradigm series insulin pumps are being recalled because of potential cybersecurity risks; 4,000 patients in the United States are affected.

  • 1
    News

    Aspirin shows little benefit for primary prevention of vascular disease in diabetes

    May 15, 2019

    Is aspirin for primary prevention of cardiovascular events in patients with diabetes worth the risk of adverse bleeding events?

  • 1
    News

    SGLT2 inhibitors prevent HF hospitalization regardless of baseline LVEF

    May 9, 2019

    NEW ORLEANS – “At least in my mind, we have more than enough evidence at this point to say that SGLT2 inhibitors are effective in preventing heart failure,” Dr. Mikhail Kosiborod said.

  • 1
    News

    Statin exposure associated with idiopathic inflammatory myositis

    April 15, 2019

    What is the association between exposure to statin medications and histologically confirmed idiopathic inflammatory myositis?

  • News

    Newer antihyperglycemic drugs have distinctive CV, kidney benefits

    March 12, 2019

    SGLT2 inhibitors and GLP-1 RAs have different effects on cardiovascular and kidney disease outcomes in patients with type 2 diabetes.

  • 1
    News

    Subclinical hypothyroidism boosts immediate risk of heart failure

    January 24, 2019

    CHICAGO – Large Danish study links subclinical and overt hypothyroidism to immediate risk of heart failure.

Previous1 … 11 12 13 14 15 … 18Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences